Unknown OBSERVATIONAL NCT00429065

Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

Selection of Young Patients (< 61 Years), With Good Prognosis Diffuse Large B Cell Lymphoma, According to the Immunophenotype (BCL-6 Negative) to be Treated With Chemoimmunotherapy, With R-CHOP. A Pilot Study.

Sponsor: Instituto Nacional de Cancerologia de Mexico

Conditions Non-Hodgkin Lymphoma

Interventions Rituximab

Updated 5 times since 2017 Last updated: Jan 30, 2007 Started: Jan 31, 2007 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00429065, this observational or N/A phase trial focuses on Non-Hodgkin Lymphoma and remains ongoing. Sponsored by Instituto Nacional de Cancerologia de Mexico, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2018 — Jan 2021 [monthly]

Unknown Status

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Nacional de Cancerologia de Mexico

Data source: Instituto Nacional de Cancerologia de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico